GPT and Hyperbilirubinemia: Adverse effects such as neutropenia, thrombocytopenia, anemia, AST/ALT abnormality, hyperbilirubinemia, increased creatinine, anorexia, nausea/vomiting, epigastralgia, fullness of stomach, stiffness of the finger and phlebitis were observed during treatment.